Skip to main content
AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)
Loading prices
Back to the NewsWire

Baltimoresun

Published November 12, 2026 · Updated November 13, 2026

US offering up to $4.9 million to prepare PTSD studies of psychedelic drug - Baltimore Sun

Read the full story at Baltimoresun

Crime and Public Safety · Education · Elections · Environment · Health · Lottery ... The Trump administration is committing up to $4.9 million to.

Surfaced by 3 Google Alerts

  • Psychedelic crime
  • Psychedelics africa
  • Psychedelics south america